FWM
ZYME icon

Forefront Wealth Management’s Zymeworks ZYME Stock Holding History

Forefront Wealth Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,400
Closed -$128K – 48
2022
Q4 		$128K Buy
+13,400
New +$94.2K 0.17% 42

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Forefront Wealth Management's ZYME Position: Q1 2023 in Review

Forefront Wealth Management sold out of Zymeworks (ZYME) in Q1 2023, closing a stake of 13,400 shares — an estimated $128K sold.

Forefront Wealth Management first reported a position in ZYME in Q4 2022 and held it in 1 quarter. The position peaked at $128K in Q4 2022. 115 funds tracked by Wall St. Rank hold ZYME as of Q1 2023.

  • Forefront Wealth Management reported no remaining Zymeworks position as of Q1 2023 after selling out during the quarter.
  • Forefront Wealth Management sold 13,400 Zymeworks shares in Q1 2023, an estimated $128K.
  • Forefront Wealth Management first reported a position in Zymeworks in Q4 2022 and held it in 1 quarter.
  • Forefront Wealth Management's Zymeworks position peaked at $128K in Q4 2022.
  • 115 funds tracked by Wall St. Rank held Zymeworks as of Q1 2023.

Based on Forefront Wealth Management's 13F filing for Q1 2023, filed 9 May 2023.